Butalbital/aspirin/caffeine/codeine
| Butalbital/aspirin/caffeine/codeine |
|---|
| ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Butalbital, aspirin, cafeine, and codeine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information about Butalbital/aspirin/caffeine/codeine, click here.
Synonyms / Brand Names: ASCOMP WITH CODEINE (butalbital, aspirin, cafeine, and codeine phosphate) capsule Normal 0 false false false EN-US X-NONE X-NONE ®,
Overview
Category
FDA Package Insert
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
[1] Normal 0 false false false EN-US X-NONE X-NONE